BMO Expects Canadian Banks To Outperform In 2021

In a note sent out to investors on January 3rd, BMO Capital Markets headlines “Bank Index Underperforms Again in 2020; History Suggests Outperformance in 2021.”

Sohrab Movahedi, BMO Capital Markets Canadian bank analyst, predicts that the basket of Canadian banks will outperform in 2021 after lagging behind the S&P and TSX for the second consecutive year. The Canadian bank index ended up 3.6% in 2020, while the median total return of 45 bank stocks was roughly -12%.

Movahedi writes, “since 1970, there have been three instances when the bank index underperformed the composite in consecutive years, and in each case, the banks outperformed the following year by an average of 780 bps.”

Movahedi believes this could be achieved through a multitude of paths such as earnings growth, dividend yield, and some multiple expansions and specifically identifies Bank of Nova Scotia and CIBC as the top winners. Movahedi adds that for investors who like to take the contrarian approach, they should be looking at the Canadian banks. Specifically, Bank of Nova Scotia, BMO, and National Bank of Canada over TD, Royal Bank, and CIBC.

Among the big six, CIBC was the best performer with a 7% return throughout the last year. On the flip side Laurentian was the worst performer for 2020, with a decline of 25.2%.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

First Majestic Q1 Earnings: A Bang Up Quarter

Copper’s Structural Shortage May Be Here to Stay | Colin Joudrie – Selkirk Copper

Why Barrick’s “Strong” Quarter Wasn’t So Strong | Q1 2026 Earnings

Recommended

Altamira Gold Extends Maria Bonita Footprint with 110 Metre Step-Out

Son of Mango Founder Arrested Over Billionaire Father’s Fatal Cliff Fall

Related News

Canaccord Genuity Raises Medipharm Labs’ Price Target To C$2.50

On Monday Medipharm Labs (TSX: LABS) announced an exclusive medical cannabis partnership with the European...

Tuesday, October 6, 2020, 01:29:18 PM

Trulieve Cannabis: Analyst Q1 Consensus Estimates

Trulieve Cannabis (CSE: TRUL) announced that they will be reporting their first quarter financials before...

Wednesday, May 12, 2021, 04:01:00 PM

Hive Blockchain: Canaccord Remains Positive On Outlook

On August 26th, Canaccord Genuity Capital Markets’ raised their 12-month price target on Hive Blockchain...

Monday, August 29, 2022, 02:22:00 PM

Else Nutrition: Canaccord Cuts Target To $2.00 After Financing

On June 22, Else Nutrition (TSX: BABY) announced that it raised $7.29 million by selling...

Monday, July 4, 2022, 04:33:00 PM

Cognetivity: Echelon Raises Price Target To $1.50 After Biogen Approval

Monday was a very big day for companies who are in the business to help...

Wednesday, June 9, 2021, 11:22:00 AM